ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Eli Lilly stock is tumbling after trial data from oral weight-loss drug

Announcement as on 07 August 2025

UBS slashes target price on Novo Nordisk, citing compounders, Eli Lilly threat

Announcement as on 05 August 2025

Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patients
Eli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, reducing mortality and cardiovascular risks. The SURPASS-CVOT trial revealed Mounjaro's superiority over Trulicity, showing improvements
Announcement as on 31 July 2025

Eli Lilly to roll out diabetes medicine in prefilled pen
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The KwikPen offers a convenient, once-weekly administration. It contains four fixed doses. This launch intensifies competition with No
Announcement as on 27 June 2025

Eli Lilly to launch Mounjaro KwikPen for type 2 diabetes in India
Eli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following regulatory approval. This offers a convenient option for adults with type 2 diabetes. Mounjaro, a dual GIP and GLP-1 receptor agon
Announcement as on 26 June 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1119.36
  • 12Day Average: 1127.25
  • 20Day Average: 1108.22
  • 50Day Average: 1011.9
  • 100Day Average: 1000.94
  • 150Day Average: 1018.79
  • 200Day Average: 966.15

LLY Indicators & signals

Indicator MACD (12,26,9)

1115.24, 1084.5, 37.78
Indicator MACD is in positive zone

Indicator ADX (14)

22.04, 26.81, 17.12
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 62
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Thu Jun 2026 1098.02 1088.66 to 1125.59 -1.26% 0.96 times
17 Wed Jun 2026 1112.00 1104.90 to 1121.49 -0.99% 1.14 times
16 Tue Jun 2026 1123.11 1115.50 to 1146.69 -0.67% 0.52 times
15 Mon Jun 2026 1130.66 1112.01 to 1142.94 -0.21% 0.8 times
12 Fri Jun 2026 1133.00 1132.81 to 1169.99 -2.35% 1.16 times
11 Thu Jun 2026 1160.30 1125.64 to 1170.12 2.11% 0.67 times
10 Wed Jun 2026 1136.37 1133.53 to 1166.42 -0.67% 1.28 times
09 Tue Jun 2026 1144.03 1137.75 to 1174.60 -0.34% 1.11 times
08 Mon Jun 2026 1147.88 1143.60 to 1225.00 1.32% 1.11 times
05 Fri Jun 2026 1132.89 1125.64 to 1166.29 0.66% 1.21 times
04 Thu Jun 2026 1125.49 1078.78 to 1140.46 3.9% 1 times
03 Wed Jun 2026 1083.23 1053.51 to 1093.28 1.75% 0.61 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top